Table 3.
Annual percent change (APC) in five-year relative survival rates for metastatic lung cancer patients in California (1990–2014).
Five-Year Relative Survival (1990–2010) | ||||
---|---|---|---|---|
APC | 95% CI | p<0.05 | ||
Overall | 4.05 | 3.47 | 4.64 | <0.01* |
Age at Diagnosis | ||||
20–64 years | 4.23 | 3.52 | 4.95 | <0.01* |
65–74 years | 5.04 | 3.80 | 6.29 | <0.01* |
≥75 years | 5.15 | 3.91 | 6.41 | <0.01* |
Sex | ||||
Male | 4.04 | 3.13 | 4.95 | <0.01* |
Female | 4.35 | 3.67 | 5.03 | <0.01* |
Race/ethnicity | ||||
NHW | 4.09 | 3.46 | 4.73 | <0.01* |
NHB | 3.58 | 2.13 | 5.05 | <0.01* |
Hispanic^ | ||||
1990–1997 | −5.42 | −14.26 | 4.32 | 0.25 |
1997–2010 | 5.68 | 2.74 | 8.70 | <0.01* |
API | 4.2 | 2.86 | 5.56 | <0.01* |
Histology | ||||
Small-Cell | 2.22 | 0.84 | 3.62 | <0.01* |
Squamous | 2.29 | 1.17 | 3.42 | <0.01* |
Adenocarcinoma | 5.66 | 4.73 | 6.60 | <0.01* |
Large Cell | 4.41 | 2.22 | 6.65 | <0.01* |
NSCLC NOS | 4.97 | 3.76 | 6.20 | <0.01* |
Other | 1.92 | −0.92 | 4.83 | 0.17 |